drugset / Trial / NCT03502902

The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects

NCT03502902 ↗

Phase 1 Completed 55 enrolled Sunshine Lake Pharma Co., Ltd. Covance · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Phase I, Double-blind, Placebo-controlled, Single Oral Dose, Safety, Tolerability, and Pharmacokinetic Study, Incorporating an Evaluation of the Effect of Food on the Pharmacokinetics of HEC68498 in Healthy Male and Female Subjects

Timeline

Start
2018-04-26
Primary completion
2019-03-15
Completion
2019-03-15

Drugs

EvaluationDrugModalityDoseRoute
Subject HEC68498 Unknown — Oral